Mary Fisher, Chief Operating Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,500 shares at $24.91 ($182K) on 2007-05-01, disclosed to the SEC on 2007-05-01.
Scheduled sale ($182k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.86 | 500 | $12K | 6.6% |
| 2 | $23.88 | 500 | $12K | 6.6% |
| 3 | $24.06 | 600 | $14K | 7.9% |
| 4 | $24.08 | 400 | $10K | 5.3% |
| 5 | $24.15 | 500 | $12K | 6.6% |
| 6 | $24.20 | 500 |
| $12K |
| 6.7% |
| 7 | $24.25 | 500 | $12K | 6.7% |
| 8 | $24.26 | 1,000 | $24K | 13.3% |
| 9 | $24.29 | 500 | $12K | 6.7% |
| 10 | $24.31 | 500 | $12K | 6.7% |
| 11 | $24.34 | 500 | $12K | 6.7% |
| 12 | $24.44 | 400 | $10K | 5.4% |
| 13 | $24.45 | 100 | $2K | 1.3% |
| 14 | $24.56 | 457 | $11K | 6.2% |
| 15 | $24.57 | 500 | $12K | 6.8% |
| 16 | $24.91 | 43 | $1K | 0.6% |
| Total | $24.24 avg | 7,500 | $182K | 100% |
| Filing → |
| OVAS | BUY | 2015-09-11 | $101K | — | Filing → |
| ZLTQ | SELL | 2015-01-27 | $1.7M | — | Filing → |
| ACOR | SELL | 2007-07-05 | $133K | — | Filing → |